Role of Nefopam in Rituximab Transfusion Reaction

• Status: Not yet recruiting
• Trial end date: 2023-11-20
• Target enrollment: 0
• Participant gender: All

Summary

the patients will be taken nefopam ampule 50 mg before rituximab in the first group while the second group will be taken diphenhydramine ampule 10 mg before rituximab in the second group

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Ministry Of Health / Nineveh Health Directorate
• Treatments: Diphenhydramine; Nefopam; Promethazine

Criteria

Inclusion Criteria:

• 18 - 80 years old male and female will be taken rituximab

Exclusion Criteria:

• less than 18 years old more than 80 years old diabetic patients